4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-030637
CEO and CFO bought 2,000 shares at $13.81 ($27,620)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-08-06 | Purchase | +2,000 | $13.81 | $27,620 | 5,534,602 | D |
| Open-market purchases · 2,000 sh · avg $13.81 · $27,620 | |||||||
Loading xslF345X05/ownership.xml…